Calquence Evropská unie - polština - EMA (European Medicines Agency)

calquence

astrazeneca ab - acalabrutinib - białaczka, limfocytowa, przewlekła, komórka b - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.

Livtencity Evropská unie - polština - EMA (European Medicines Agency)

livtencity

takeda pharmaceuticals international ag ireland branch - maribavir - zakażenia cytomegalowirusem - Środki przeciwwirusowe do użytku ogólnoustrojowego - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). należy uwzględnić oficjalne zalecenia dotyczące właściwego stosowania leków przeciwwirusowych.

Pyrukynd Evropská unie - polština - EMA (European Medicines Agency)

pyrukynd

agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.

Vafseo Evropská unie - polština - EMA (European Medicines Agency)

vafseo

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - preparaty antyanemiczne - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

Onpattro Evropská unie - polština - EMA (European Medicines Agency)

onpattro

alnylam netherlands b.v. - patisiran sodu - amyloidoza, hotel rodzinny - inne leki na układ nerwowy - onpattro jest wskazany do leczenia dziedzicznych транстиретина pośredniczącego amyloidozy (hattr amyloidoza) u dorosłych pacjentów z etapu 1 lub 2 fazy polineuropatii.